Developer of a health formulation comprised of GRAS (Generally Regarded As Safe) components.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Drogheda
State: Louth
Zip:
Country: Ireland
Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. This formulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2014 | Seed Round | - |
Partisan Management Group Partisan Management Group |
1/2017 | Seed Round | - |
Partisan Management Group Partisan Management Group |
1/2017 | Seed Round | 1 | - |
Partisan Management Group Partisan Management Group |
6/2014 | Seed Round | 1 | - |
Partisan Management Group Partisan Management Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|